This page follows insider dealings at Parexel International Corp as filed with SEC (Form 4). Nothing new has been filed by managers of Parexel International Corp in twelve months, the latest record being from 4 October 2017.
Since 2016, the database holds no purchases and 13 sales by insiders of the company.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended June 2017 · cache
25 of 104 declarations
Parexel International Corp is a company specializing in clinical research and drug development services. It provides solutions to pharmaceutical and biopharmaceutical companies to accelerate the market entry of new treatments.
Purchases our model currently ranks for the recommendations list.
All recommendations